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ABSTRACT

Cell Toxicity and Uptake of RRR-alpha-Tocopheryl Polyethylene Glycol 1000 Succinate
(TPGS) by Various Cell Lines In Vitro

by
Christelle Komguem Kamga
This research focused on investigating and comparing the cytotoxicity and cellular uptake
of RRR-alpha-tocopheryl polyethylene glycol succinate (TPGS) with that of alphatocopheryl succinate (α-TS). Both TPGS and α-TS are water-soluble forms of vitamin E
with important clinical applications. Cytotoxicity assays with RAW 264.7 and LNCaP
cells incubated overnight with TPGS or α-TS at concentrations ≥ 12.4 µM suggest that αTS is more cytotoxic than TPGS. Macrophages were found to be more sensitive than
LNCaP cells when treated with similar concentrations of α-TS. For both cell lines, most
of the TPGS or α-TS taken up remained esterified after 24 hours. Our results suggest that
cell death was due to TPGS and/or α-TS and not alpha-tocopherol. A parahydroxyanilide of α-TS (p-HATS) that could be used to distinguish between cellular
TPGS and α-TS was studied. It was found that p-HATS can be detected
electrochemically and that it is hydrolyzed to α-TOH.
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CHAPTER 1
INTRODUCTION
Vitamin E was labeled the ‘sex vitamin” soon after its discovery in 1922 by
Herbert Evans and Katharine Bishop, because of its important role in mammalian
1, 2

reproduction and fertility

. After its lipophilic components, tocopherols and

tocotrienols were isolated and characterized, research focused on vitamin E’s role as
2

antioxidant . Vitamin E was shown to inhibit lipid peroxidation triggered by free
3, 4

radicals

. Reactions of the latter with cellular components have been associated with
5

the pathophysiology of some malignancies including cancers of the lungs, ovaries , skin,
6

prostate, colon , stomach, and esophagus. Alpha-tocopherol, the predominant form of
vitamin E in human and animal tissues, has been shown to scavenge lipid peroxyl
2, 3, 4

radicals, which are the chain-carrying species in lipid peroxidation

. The antioxidant
7, 8, 9

property of vitamin E suggests it might be a potential agent for tumor prevention

.

In our study, we used RRR-alpha-tocopheryl polyethylene glycol 1000 succinate
10

(TPGS), a water-soluble source of alpha-tocopherol for patients with fat malabsorption .
In this investigation, TPGS toxicity and uptake by different cell lines was studied in time
and dose-dependent experiments. RAW 264.7 macrophage cells were used because they
contain esterases that can hydrolyze TPGS. Studies were also carried out with androgendependent human prostate cancer cells (LNCAP).

Vitamin E Compounds
Natural Forms of Vitamin E
Vitamin E is a common name used to designate eight natural compounds of two
types, tocopherols and tocotrienols. As the structures in Figure 1 show, these compounds
all possess a chroman ring with different substitution patterns of methyl groups at
1

positions 5 and 7 of the head group (α−, β−, δ−, γ-), and a 16-carbon side chain .
However, while tocopherols have a saturated phytyl side chain with two chiral centers at
carbons 4’ and 8’, tocotrienols possess an unsaturated side chain with double bonds at
positions 3’, 7’, and 11’.
- 10 -
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Figure 1. Structures of naturally occurring forms of Vitamin E. Chiral centers are
indicated by an *.
Of all natural forms, α-tocopherol has the highest biological activity and is the
1

predominant form of this vitamin found in human tissues . It also exists in a synthetic
form. However, by virtue of the three chiral carbons at positions 2, 4’ and 8’, the
synthetic all-racemic-α-tocopherol is a mixture of eight stereoisomers rather than a single
1

compound . The natural configuration of RRR-α-tocopherol is 2R, 4’R; 8’R. Chemical
structures of d-α-tocopherol stereoisomers are given in the appendix.

- 11 -

A Special Ester Derivative of Natural Alpha -Tocopherol: TPGS
Alpha-tocopherol can be esterified by reaction with acids to form α-tocopheryl
1

acetate, succinate, linoleate, or nicotinate . In the body, enzymes called esterases remove
these acids, liberating the active α-tocopherol. Further esterification of the acid group of
RRR-α-tocopheryl succinate by polyethylene glycol 1000 (PEG 1000) produces RRR-αtocopheryl polyethylene glycol 1000 succinate (TPGS), whose structure is shown in
Figure 2. TPGS is amphipatic and, in contrast to other fat-soluble forms of vitamin E, is
water-soluble and forms its own micelles. This unique property has been used clinically
8

to supply Vitamin E to patients with poor production of bile and pancreatic enzymes .

Figure 2. Chemical structure of TPGS. The diester has a polyethylene glycol group
substituted at the carboxyl group of RRR-α-tocopheryl succinate. PEG stands for
polyethylene glycol 1000.
TPGS hydrolysis would yield PEG and α-tocopheryl succinate (α-TS), and
further hydrolysis of α-TS produces α-tocopherol (α-TOH) and succinate (S) as shown in
equations (1) and (2). Alternatively, α-TOH, S, and PEG could directly be produced from
TPGS by hydrolysis as given in equation (3).
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Hydrolysis products of TPGS are:
TPGS

α-TS + PEG

(1)

α-TS

α-TOH + S

(2)

TPGS

α-TOH + S + PEG

(3)

Free Radicals
Free radicals are usually highly reactive chemical species carrying an odd,
11

unpaired electron in their valence shell . They are generally unstable, short-lived, and
capture an electron from another molecule to achieve stability. The molecule that loses its
electron becomes a free radical itself, beginning a chain reaction. In vivo, free radicals
can react with lipids, proteins, carbohydrates, and DNA. Damage caused by these
reactions has been associated with the pathophysiology of several diseases such as
12, 13, 14

cancer, arthritis, aging, and heart disease

.
11

Oxyradicals result from the reduction of molecular oxygen . Reduction is a gain
of electron(s) by a chemical species while oxidation is a loss of electron(s). The
conversion of O2 to H2O involves a total gain of 4 electrons as depicted by the scheme in
Figure 3. Intrinsically, the use of oxygen by aerobic organisms is associated with the risk
11

of oxygen free radicals generation . Normal metabolic processes within the body
(endogenous sources) that generate free radicals include phagocytosis, cell respiration,
and oxygen transport between lungs and tissues. Exogenous sources of free radicals
include ionizing radiations from industrial exhausts, sunrays, environmental pollutants
11

such as ozone, and tobacco . Common examples of oxygen-derived damaging species
are given in Table 1.
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Figure 3. Reduction of molecular oxygen to water. It proceeds through steps that produce
oxyradicals or their precursors.
Table 1: Examples of oxygen-derived damaging species.
Radicals

Name

Non-radicals

Name

O2•−

Superoxide radical

H2O2

Hydrogen Peroxide

HO•

Hydroxyl radical

ROO•

1

O2

Singlet oxygen

Peroxyl radical

HOCl

Hypochlorous acid

HO2•

Hydroperoxyl radical

LOOH

•

Lipid peroxyl radical

O3

LO2
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Lipid
hydroperoxide
Ozone

Oxidative Stress and Antioxidants
Oxidative stress is a physiological state that occurs when the generation of
reactive oxygen species in a system exceeds the system’s ability to neutralize and
15

eliminate them . Oxidation of various cellular components including DNA, lipids, and
carbohydrates can lead to DNA damage, mitochondrial malfunction, cell membrane
16

damage, and eventually cell death . To suppress excessive oxyradicals and insure that
tissues and metabolic processes can function properly, antioxidants are required.
Antioxidants are substances that, when present in small amounts, inhibit reactions
17, 18

promoted by oxygen and/or free radicals. Antioxidants operate through four routes

:

a) They break chain reactions: alpha-tocopherol breaks lipid peroxidation
b) They decrease the concentration of reactive oxygen species : Glutathione
peroxidase is an enzyme that removes H2O2 and lipid hydroperoxides ( LOOH)
as shown below:

H2O2 + 2GSH

2H2O + GSSG

LOOH + 2GSH
GSH: Reduced glutathione
c)

LOH + H2O + GSSG
GSSG: Oxidized glutathione

They scavenge initiating radicals. Superoxide dismutase (SOD) traps
superoxide radicals as shown below:

2 O2- + 2H+

3

2H2O + O2

O2 + H2O2
H2O2

d) They chelate transition metal catalysts. Ascorbic acid binds to transition metals.

- 15 -

Natural antioxidants include enzymes like catalase, glutathione peroxidase,
19

superoxide dismutase (SOD), and glucose oxidase . Vitamin E, ascorbic acid,
carotenoids, flavonoids, and ubiquinol are other major chemical antioxidants.
Antioxidants prepared synthetically include butylated hydroxytoluene (BHT), pyrogallol,
and the metal chelator ethylene diamine tetra acetate (EDTA).

O
C
O O
C C H2
O
O

N
C H2

O

O

N
C H2

M
C

C H2

C H2
C H2

C
O

Figure 4. Structure of EDTA. The metal ion (M) is sequestered within the complex
20

thereby preventing its redox cycling .
OH

(H3C)3C

OH
C(CH3)3

HO

CH3

2,6-ditertiary-butyl-4-methyl phenol
BHT

Figure 5. Structures of pyrogallol and BHT.
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Figure 6. Structures of some naturally occurring antioxidants.
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Antioxidant Properties of Vitamin E
Vitamin E compounds possess antioxidant properties due to the hydroxyl group at
C6 of the chroman ring that can donate its hydrogen atom to terminate free radical chain
reactions. Ones of the primary targets of free radicals in the body are polyunsaturated
12, 13

fatty acids (PUFA). They undergo a process called lipid peroxidation

. It has been

experimentally shown that α –tocopherol acts as an antioxidant by scavenging lipid
peroxyl radicals (reaction 3 in Figure 7), which are the chain carrying species in lipid
peroxidation. The steps involved in fatty acids autoxidation are summarized in Figure 7.

Figure 7. Reaction steps in fatty acids autoxidation.
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The initiation step (reaction 1) is the abstraction of a hydrogen atom from the bisallylic methylene of a PUFA by various agents including metal ions, UV and γ-radiations,
21

and synthetic radical initiators . The subsequent reaction (reaction 2) of the fatty acid
radical with oxygen is exceedingly fast (>109M-1s-1) and produces a fatty acid peroxyl
radical. Chain propagation occurs when the peroxyl radical removes a hydrogen atom
form another fatty acid molecule (reaction 3). Encounter of the peroxyl radical with a
22

tocopherol molecule terminates the chain reaction (reaction 4) . The tocopheroxyl
radical formed is relatively stable due to the delocalization of the unpaired electron about
23

the fully substituted chroman ring system .

Figure 8. Reaction of an α-tocopherol molecule with a fatty acid peroxyl radical.

Figure 9. Resonance stabilization of tocopheroxyl radical.
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The antioxidant potency of α-tocopherol is expressed by the relative rates of
reactions (3) and (4) in Figure 7. The inhibition reaction is exceedingly fast compared to
the propagation step. α-Tocopherol also reacts with singlet oxygen, ozone, alkoxyl
radicals, and superoxide. It can be observed from Table 2 that the peroxyl radical has the
lowest standard one-electron reduction potential among alkyl, alkoxyl, and peroxyl
24, 25

radicals. It is therefore the most prevalent target of Vitamin E compounds

.

Table 2. Standard one electron potential reduction for different redox systems.

The effectiveness of α-tocopherol as an antioxidant is further enhanced by its
regeneration from its oxidized products. The recycling of α-tocopherol in vitro from its
tocopheroxyl radical form, mediated by ascorbic acid and coenzyme Q, has been
26, 27

demonstrated to proceed as shown in Figures 10 and 11 below

:

Figure 10. Regeneration of α-tocopherol mediated by L-ascorbic acid.
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Figure 11. Regeneration of α-tocopherol mediated by ubiquinol.
Esters of α-tocopherol have a blocked hydroxyl group and therefore do not
exhibit antioxidant function until the attached acid is removed by esterases in the body.
Cancer and Vitamin E
In recent years, cancer has surpassed heart disease as the leading cause of death
among people under 85 in the US. More than a million new cancer cases are expected in
28

2005 with the main killer being lung cancer . Prostate cancer and breast cancers are the
biggest killers among men and women respectively. Previous researchers have
investigated the role of vitamin E homologues in helping fight and eventually prevent
cancer.
High blood levels of α-tocopherol have been shown to cut the risk of prostate
29

cancer by about 32% in clinical trials . In other experiments, α-tocopheryl succinate
induced apoptosis in androgen-dependent human prostate cancer (LNCaP) cells without
30

any effect on normal PrEC human prostate epithelial cells . However, to date, no study
has been carried out on these cell lines with TPGS as a source of vitamin E. αTocopherol and α-tocopheryl succinate being two hydrolysis products of TPGS suggests
the effects of this compound on cell lines are worthwhile investigating. In our study, the
comparative toxicity and uptake of TPGS and α-tocopheryl succinate on RAW 264.7
macrophages and LNCaP cells were investigated.
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Cell Viability Assays and Cell Death
Cell viability measurements are used to assess the number of healthy cells in a
sample. This can be done either by counting the number of healthy cells directly using a
hemocytometer or by measuring an indicator of cell growth. Two parameters are usually
considered: metabolic activity or cell membrane integrity. An increase in cell viability
indicates cell growth, whereas a decrease in viability might be a sign of a toxic substance
or inadequate culture conditions.
Mitochondrial activity in cell populations was measured using 3-(4, 5dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT). This is a salt that is
reduced to blue-black formazan crystals in the mitochondria of live cells. It is therefore a
measure of cell viability. Formazan crystals dissolve upon addition of an organic solvent
like dimethyl sulfoxide (DMSO) to form a deep purple solution that absorbs light at 575
nm. Figure 12 shows the chemical structure of MTT.
Dye –exclusion assays take advantage of the ability of live cells with an intact
cytoplasmic membrane to retain or exclude some dyes. The live cells population in
samples was measured using a fluorophore called 5, 6-carboxyfluorescein diacetate
(CFDA). This uncharged molecule penetrates into cell membranes and is converted in
live cells by esterases to 5, 6-carboxyfluorescein, which as a dianion, is membrane
impermeant. Only cells with intact plasma membranes retain the hydrolyzed form of the
dye therefore accounting for the number of live cells. Carboxyfluorescein emits green
fluorescence at wavelength 520 nm when excited at 485 nm.
Dye-exclusion assays can also be used to determine the population of dead cells
in a sample. Propidium iodide (PI) is a membrane-impermeant dye that penetrates only
into cells having a damaged plasma membrane and produces a red fluorescence upon
binding to double-stranded nucleic acids and excitation at 485nm. It is completely
excluded by live cells. The fluorescence signal emitted at 650 nm is directly proportional
to the number of dead cells.
Cell death can occur by either of two distinct mechanisms: necrosis or apoptosis.
Apoptosis sometimes referred to as “programmed” or “normal” cell death is the
physiological process by which unwanted or useless cells are eliminated during growth
and other normal biological processes. Necrosis, in contrast, occurs when cells are
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exposed to extreme variance from physiological conditions, which may result in damage
to the plasma membrane. It is therefore referred to as “accidental” cell death.

Br
N

N

S

CH3

N
N

N

MTT

CH3

Figure 12. Chemical structure of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT).

I

N

NH2

N
I

Figure 13. Chemical structure of propidium iodide (PI).
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O
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5

Figure 14. Structures of 5, 6-carboxyfluorescein diacetate and 5, 6-carboxyfluorescein.
Theory of High Performance Liquid Chromatography Operation
High performance liquid chromatography (HPLC) with electrochemical detection
was used to measure α-tocopherol in samples. Chromatography is an analytical technique
used to separate the components of a mixture based on their interaction with a stationary
phase and a mobile phase. HPLC uses a liquid mobile phase (eluent) to carry the analytes
through a column packed with a stationary material (adsorbent). The higher versatility of
HPLC over other chromatographic techniques lies in the variety of eluents and absorbents
31

that can be used . In adsorption chromatography, the active sites of the adsorbent
interact with the functional groups of the analytes by noncovalent bonds, nonpolar
interactions, Van der Waals forces, and hydrophobic interactions. Compounds less tightly
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bound are eluted out by the mobile phase earlier and effective separation of classes of
compounds can be achieved. There are two modes of adsorption chromatography based
on the polarity of the phases: normal phase chromatography which uses a strongly polar
adsorbent and a nonpolar mobile phase. The second mode is reversed-phase
31

chromatography in which it is the inverse .
In our study, reversed-phase chromatography was used and the internal standard
was rac-5, 7-dimethyltocol (5, 7- DMT). An internal standard is a known amount of a
31

compound, different from the analyte, which is added to the unknown . Signal from the
unknown is compared with that from the internal standard to find out how much analyte
is present. Rac-5, 7-dimethyltocol was used as internal standard because its
chromatographic and oxidation properties are similar to those of tocopherols. Figure 15
shows the structure of 5, 7-DMT.
Electrochemical detection was chosen as the detection method because it responds
to electroactive substances and has high selectivity and sensitivity (picogram to
31

femtogram level) . The compound of interest is either oxidized (reduced) at a specific
potential and the current (amperes) is proportional to the analyte concentration. When
only a small fraction of the sample (5 to 15%) is oxidized (reduced) the detector is
referred to as an amperometric detector. However, the entire sample can be oxidized
(reduced) so that the signal is proportional to the total amount of the analyte in the
injected sample. This type of detector is called coulometric and is generally more
31

sensitive and stable than amperometric detection . A diagram representing the main
components of the HPLC system is shown in Figure 16.

CH3

HO
H3C

C16H33
O

CH3

H

rac-5,7-dimethyltocol
Figure 15. Chemical structure of rac-5, 7-dimethyltocol.
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31

Figure 16. Components of the HPLC system. PF stands for prefilter .
The constant flow pump delivers the mobile phase to the pre-filter where
particulate impurities are removed. The pressure damper compensates for the pulsations
in the eluent due to the pump action. The guard cell oxidizes (reduces) any
electrochemically active material from the mobile phase. This reduces background
current and baseline noise hence maximizing the sensitivity of the detector. The sample
can be introduced into the mobile phase, without depressurizing the system, with the use
of a microliter syringe and a loop-type injection valve. The detector emits a response due
31

to each component eluting from the column and signals a peak on the chromatogram .
In a sample containing rac-5, 7-dimethyltocol and α-tocopherol, the former elutes
first because of its greater polarity. A sample of chromatogram showing the eluting
positions of 5, 7-DMT and α-tocopherol in reversed-phase HPLC is represented in Figure
17.
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Figure 17. The elution order of rac-5, 7- DMT and α-tocopherol in reversed phase
HPLC.
A Para-Hydroxyanilide Derivative of RRR-α-Tocopheryl Succinate: p-HATS
The last part of this study focused on the investigation of some critical properties
of a compound referred to as p-HATS, which stands for para-hydroxyanilide of RRR-αtocopheryl succinate. It has a molecular weight of 639 g/mol and is soluble in ethanol.
The chemical structure of p-HATS is shown in Figure 18.

Figure 18. Chemical structure of p-HATS.

- 27 -

It can be noted from the structure in Figure 18 that the PEG 1000 end that exists
in TPGS is replaced by para-hydroxyaniline. This makes p-HATS a very polar
compound compared to TPGS. p-HATS also has a free hydroxyl group. Therefore, unlike
α-TS, it is electroactive and can be detected by HPLC/ECD. This property could be used
to measure the amount of α-TS in a sample used as a starting reagent for the synthesis of
p-HATS. Therefore, it could be an analytical tool to determine the amount of α-TS in
cellular systems using HPLC/ECD. The chromatographic properties of p-HATS,
including the oxidation potential for its detection and its retention time relative to 5,7DMT were investigated.
A by-product of p-HATS synthesis is para-hydroxyaniline (p-HA). Its chemical
structure is shown in Figure 19 below.

Figure 19. Structure of p-HA.
p-HATS is a diester. Its possible hydrolysis products include p-HA, α-TS,
succinate, and α-TOH. Therefore, in addition to its ability to be detected by HPLC/ECD,
it might be a potential source of α-TOH. As part of this research, a solvent appropriate
for the extraction of p-HATS was determined and an attempt was made to determine the
products of p-HATS hydrolysis.
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CHAPTER 2
METHODOLOGY

Reagents and Materials
RAW 264.7 macrophages and LNCaP cells were purchased from American Type
Culture Collection (Manassas, VA). RPMI-1640 medium with phenol red, fetal bovine
serum (FBS), penicillin (10,000 units/ml), streptomycin (10,000µg/ml), dimethyl
sulfoxide (DMSO), and 1x phosphate buffer saline (PBS) were purchased from Life
Technologies (Grand Island, NY). TPGS was donated by Tennessee Eastman
(Kingsport, TN), α-tocopherol succinate, α-tocopherol, p-HATS, and p-HA were
synthesized and generously provided by Dr. John Hyatt. Rac-5, 7-dimethyl tocol was
purchased from Matreya (Pleasant Gap, PA). Propidium iodide and 5, 6carboxyfluorescein diacetate were purchased from Invitrogen Corporation (Carlsbad,
CA). Pluronic acid, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) , Ethylene diamine tetra acetic acid (EDTA), citric acid, sodium hydroxide,
butylated hydroxytoluene (BHT), ascorbic acid, pyrogallol, and Triton X-100 were
purchased from Sigma Chemical Co. (St. Louis, MO). Hexane, methylene dichloride, and
ethyl acetate were purchased from Fisher Scientific (Fair Lawn, NJ). Ethanol was
purchased from Aaper Alcohol and Chemical Co. (Shelbyville, KY).
Costar 75 cm2/tissue culture flasks (sterile) and cell culture plates (sterile) were
purchased from Costar (Cambridge, MA). Cell scrapers and pipettes were from Fisher
Scientific (Fair Lawn, NJ). Syringe filters, (0.22µM and 0.45 µM) purchased from
Gelman Science (Ann. Arbor, MI).
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Preparation of Solutions
Cell culture medium Prepared by mixing 450 mL of RPMI-1640, 50 mL of FBS, 2.5 mL
of a 50mg/mL penicillin/streptomycin solution.
Polished water De-ionized water was filtered through a Sep-Pak cartridge (Water,
Atlanta), and stored at 4ºC.
NH4OAc/HOAc buffer (pH=4.4) Ammonium acetate NH4OAc (38.55 g) was dissolved
in 500 mL of polished water. The pH was adjusted to 4.4 with acetic acid (HOAc) and
stored at 40C.
BHT solution in hexane10ug/mL A 10.0 mg sample of BHT was dissolved in 1.0 liter
hexane.
Citric acid solution (3.0 mM) 0.0288 g citric acid (MW=192.1 g/mol) was dissolved in
polished water and diluted to a final aqueous volume of 50 mL and stored at 40C.
Mobile phase used in HPLC/ECD An 80.0 mL aliquot of 1M NH4OAc/HOAc buffer
(pH=4.4) was mixed with 4.0 mL of 3.0 mM citric acid and polished water was added to
give a final volume of 400 mL. The mixture was filtered through a 0.22 µM filter
Millipore then mixed with 3600 mL of MeOH.
Mobile phase”Lite” polished water (400.0 mL) was filtered through a 0.22 um filter
Millipore then mixed with 3600 mL of HPLC grade MeOH.
Solution of BHT (220.36 g/mol) in 100% ethanol A mass of 0.0025 g BHT was dissolved
in 100 mL of ethanol.
Ascorbic acid (176.1g/mol) solution: Prepared by dissolving 0.75 g in 5 mL of distilled
water.
Pyrogallol (126.1 g/mol) solution: Prepared by adding 1.25 g of solid pyrogallol to 5 mL
of ethanol.
Saturated KOH solution: KOH (14.508 g) was added to 10 mL of de-ionized water at
room temperature.
Alpha-tocopheryl succinate (α-TS) stock solution: A mass of 0.0008 g α-TS (530.79
g/mol) was dissolved in 20 mL of ethanol.
Solutions of 5, 7-dimethyltocol: Working solutions were prepared from a 0.20 µM stock
solution by dilution with ethanol.
Alpha-tocopherol solutions: A 10 mM stock solution was diluted with ethanol.
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TRIS solution (0.2 M): A mass of 2.42 g was dissolved in 100 mL of distilled H2O.
Triton X-100 solution (2% w/v): Prepared by dissolving 0.2 g of triton X-100 in 10 mL
of distilled water.
EDTA tetra sodium (MW 380.2 g/mL) solution (1 M): Prepared by adding 3.80 g of
EDTA to 10 mL of distilled water.
TPGS solutions: A stock solution (99.14 µM) was prepared by dissolving 0.0075 g of
TPGS (1513 g/mol) in 50 mL of boiling culture medium then the mixture was stirred for
2 hours and filtered though a 0.22uM filter. Working solutions were prepared by diluting
the stock solution with culture medium.
Lysis buffer: A 10x solution was prepared by adding 20 mL of 0.2 M HCl and 25.0 mL
of 0.2 M TRIS to a 50 mL graduated cylinder. Then, 2.5 mL of 2% triton X-100, 0.5 mL
of 1 M EDTA solution, and 2.925 g of NaCl were added to the cylinder and the pH
adjusted to 7.5. The total volume was brought to 50.0 mL with deionized water and the
mixture filtered (Nalgene # 122-0045; 115 mL top bottle, 0.45 um pore size) and stored
in 10 mL plastic bottles at –200C. Prior to use, the lysis buffer was diluted 10-fold with
deionized water.
PI solutions: A 1mg/ml stock solution was diluted with cell culture medium to the
required working concentrations.
CFDA solutions: A 20% w/v Pluronic F-127/ DMSO solution was prepared by diluting
200 µg of Pluronic F-127 in 800 µL anhydrous DMSO and the solution was warmed
gently at ~ 400C. To 500 µL of this mixture, 0.5 mg of CFDA (460 g/mol) was added.
The final 2.17 mM stock solution was stored in molecular sieves.
MTT solutions: A 2.5 mg sample of MTT (335.43g/mol) was dissolved in 5 mL culture
medium.
p-HATS solutions: A stock solution was prepared by dissolving 0.0016 g of solid pHATS (639 g/mol) in 10 mL of ethanol. This was then diluted with ethanol for lesser
concentrations.
p-HA solution: Prepared by dissolving 0.0025 g of solid p-HA (100 g/mol) in 10 mL of
ethanol.
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Methods
All cell lines were cultured in sterile flasks at 370C in a humidified incubator with
95% air and 5% CO2. After reaching confluence, they were seeded either in 96-well
plates for cell viability studies or in 12-well plates for uptake analyses.
1.

Cells were counted using a hemocytometer. They were then seeded into plates and
incubated overnight.
Culture medium was removed and the vitamin E homologue (either TPGS or α-TS)

2.

working solution(s) added to the cells. Vitamin E solutions of different
concentrations were used in dose-dependent experiments, at a single time-point.
Different incubation periods were considered as a single concentration for timedependent studies.
Cell Viability Assays
The three viability assays (PI, CFDA and MTT) were performed according to the
scheme represented in Figure 20.

CELL CULTURE CONDITIONS
•
Cell counting
•
Treatment with Vitamin E

CELL VIABILITY ASSAYS

PI

CFDA

MTT

RAW 264.7 macrophages, LNCaP cells

Figure 20. Experimental Design in Cell Viability Study.
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Dyes Addition. After incubation with the vitamin E homologue solution(s), dyes
were added. For each experiment all three assays were conducted in the same 96-well
plate. Fluorescence was measured in PI and CFDA assays using a Fluostar Galaxy
Microplate Reader from BMG Labtechnologies in the standard fluorescence
configuration using bottom-bottom optics modes. Absorbance of samples was measured
in MTT assays using a SpectraMax 190 Microplate Reader from Molecular Devices.
Figure 21 shows the layout adopted for dose-dependent measurements.
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Figure 21. Layout of the 96-well plate in dose-dependent cell viability assays. The wells
are labeled according to their contents. C: non-treated cells in culture medium, used as
control.C1, C2, C3, and C4 are increasing concentrations or vitamin E homologues. S:
cells treated with staurosporine, used as negative control. B: cells in medium that were
not treated with a fluorophore, used as blank.
For time-dependent assays, slight modifications of the above layout were used.
All wells contained cells treated with the same concentration of vitamin E. Increasing
time points were represented as T1, T2, and T3. The blank used was the same as
previously. Figure 22 shows the plate layout used in time-dependent experiments.
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Figure 22. Plate layout in time-dependent experiments.
PI Assay. A 100 µL aliquot of 3 µM PI was added to each well to give a final
volume of 200 µL and a 1.5 µM PI concentration. The cells were incubated for 10
minutes with PI then the fluorescence measured (excitation 485nm/emission 650 nm).
CFDA Assay. Medium was first removed and cells washed three times with 1x
PBS. A 100 µL aliquot of 1.1 µM CFDA was added to each well. After incubating for 10
minutes, fluorescence was measured (excitation 485 nm/emission 520 nm).
MTT Assay. Medium was first removed and 100 µL of the 0.5mg/mL MTT
solution added to each well. Cells were incubated for 30 minutes for formation of blue
formazan crystals. MTT was carefully removed from each well without disturbing the
crystals and a 100 µL volume of DMSO added to dissolve them. Absorbance was
measured at 570 nm after 30 minutes.
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Cellular Uptake and Hydrolysis of TPGS and α-TS
An analytical method was devised to measure cellular uptake and hydrolysis of
TPGS. Experiments were carried out using TPGS-treated cells and also with α-TStreated cells. The experimental design used in this part of the study is shown in Figure 23.
1. Cell Culture Conditions.
2. Cell lysate Preparation.

Addition of antioxidants (ascorbic acid, pyrogallol and EDTA) and
ethanol to cell lysate.

UPTAKE
Total cellular tocopherol content
(TPGS+ α-TS+ α-TOH)

HYDROLYSIS
Free cellular tocopherol content
(α-TOH)
No addition.

1. Addition of saturated KOH in
the dark.
2. Incubation for 5 minutes in a
700C water-bath.
3. Allow for cooling.

1.
2.
3.
4.
5.
6.

EXTRACTION
Addition of hexane, distilled water and internal standard.
Vortexing of each sample for 2 minutes then centrifugation for 10 minutes
at 4000xg.
Removal of a hexane layer aliquot.
Drying under nitrogen.
Reconstitution in mobile phase.
Vortexing for 1 minute then filtration through a 0.22 µM filter.

ANALYSIS using HPLC/ECD
Figure 23. Diagram of experimental design for measurement of cellular tocopherol
content.
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Cell Lysate Preparation.
1. Cells were incubated in a 12-well plate with TPGS or α-TS. Time and dosedependent experiments were carried out concurrently in the same well plate.
2. The medium was removed and the cells were washed three times with 1xPBS.
They were overlayed with 1.5 mL of lysis buffer and scraped.
3. Cell lysate was collected in glass vials and submitted to two cycles of freezing
and thawing.
Addition of Ethanol and Antioxidants. Cell lysate from each well was equally
divided and put in two separate vials: one for the measurement of cellular total tocopherol
and the other for free tocopherol. In separate glass vials, for every 500 µL of cell lysate,
500 µL of ethanol, 100 µL of ascorbic acid, 100 µL of pyrogallol, and 200 µL of EDTA
were added. To determine the total tocopherol content, the vial contents was hydrolyzed
with saturated KOH as outlined in figure 21. Free tocopherol determination did not
require any KOH hydrolysis.
Extraction. Both vials contents were then extracted into hexane. For every 500
µL of initial cell lysate, 1 mL of hexane containing 10 µg BHT, 250 µL of distilled water
and 250 µL of rac-5, 7- dimethyl tocol as internal standard were added to each vial. The
mixture was then vortexed for 2 minutes on a Maxi-Mix 1 mixer from
BARNSTEAD/THERMOLYNE (Dubuque, IA). Samples were centrifuged for 10
minutes at 4000xg in an International Centrifuge from International Equipment Co.
(Needham, MA). A 500 µL aliquot of the supernatant hexane layer was removed from
each vial and dried under nitrogen. A 200 µL volume of mobile phase was then added
and the mixture vortexed for 1 minute, filtered through a 0.22 µm syringe-driven filter
unit from Millipore Corporation (Billerica, MA), and either analyzed directly or kept at 200C until used.
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Measurement of Tocopherol Content Using HPLC/ECD. Cellular tocopherol
content was measured using a HPLC equipped with a Coulochem II Electrochemical
Detector, a ESA Model 580 Solvent Delivery Module, a HR-80 column(C 18, 3 µm, 8
cm), a Model 5011 Analytical Cell, a Model 5020 Guard Cell (Chelmsford, MA), a PE
Nelson 900 Series interface with PE Nelson Tuberchrom V4 Software (Perkin Elmer, San
Jose, CA) using a Dell computer. Throughout the study, the flow rate was maintained at
1.5 mL/mn with E=300 mV, E2=400 mV. E and E2 are the potential of the guard cell and
the analytical electrode, respectively.
Response Factor Determination. To use an internal standard, a known mixture of
standard and analyte is prepared and the relative response of the detector to the two
species carefully measured. Because α-tocopherol was the compound to measure, it was
used to determine the response factor relative to rac-5, 7 –dimethyl tocol. Standard
solutions of α-tocopherol and rac-5,7- dimethyl tocol were prepared and their maximum
absorbance wavelengths measured using a Cary 50 Bio UV-Visible Spectrophotometer
from Varian (Walnut Creek, CA). The standard solutions were mixed and the areas under
the peaks measured by the HPLC/ECD method. Purity of 5, 7-DMT and α-TOH
solutions was tested using HPLC with UV detection and the correction coefficients for
concentrations obtained. The response factor F was determined as shown below:
AT = area under the peak for α-TOH
ADMT = area under the peak for rac-5, 7- DMT
[T] = concentration of α-TOH
[DMT]= concentration of rac-5, 7- DMT
The response factor F is given by the formula:
AT/ [T] = F x (ADMT/ [DMT])

Once F is known, unknown concentrations of tocopherol can be obtained for subsequent
sample runs, knowing [DMT], AT and ADMT.
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[T] = (1/F) x [DMT] x (AT/ADMT)
Properties of p-HATS
Pure solutions of p-HATS were prepared in ethanol. To determine the optimal
oxidation potential for p-HATS detection, a mixture of 250 pmol p-HATS and 79 pmol
of 5, 7-DMT was prepared in mobile phase. HPLC/ECD was used to detect both
compounds at different oxidation potentials.
In order to determine a solvent suitable for the extraction of p-HATS, 500 µL of a
25 µM solution was treated with antioxidants. 5, 7-DMT was added and the extraction
carried out into four different solvents: hexane, methylene chloride, octane and ethyl
acetate. HPLC/ECD then used to detect p-HATS.
A solution of 120 pmol p-HA and 55 pmol 5, 7-DMT in mobile phase was
prepared and analyzed using HPLC/ECD.
Saponification of 500 µL of a 25 µM p-HATS solution was carried out in order to
identify the products of its hydrolysis. Extraction was done using hexane and ethyl
acetate and the compounds detected by HPLC/ECD.

- 38 -

CHAPTER 3
RESULTS
Cytotoxicity of TPGS and α-TS
Determination of Optimal PI and CFDA Concentrations in Cell Viability Assays
RAW 264.7 macrophages were seeded in a 96-well plate, incubated overnight to
adhere to the bottom of the wells, and then incubated with 2 µM staurosporine (a positive
control) for 16 hours. The population of dead cells was then evaluated using PI solutions
of varying concentrations (0.15, 1.50, 3.70, and 6.00 µM). Figure 24 shows the PI
fluorescence as a function of the dye concentration.

Figure 24. Determination of the optimum PI concentration. RAW 264.7 macrophages
were treated with 2 µM staurosporine for 16 hours. Cell viability was then assessed using
different concentrations of PI. * Statistically different from 0.15 µM PI and **
statistically different from other PI concentrations (P<0.05). Values are means ± S.E.M
from 4 wells.
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As shown in Figure 24, at PI concentrations above 1.50 µM, the strength of the
fluorescence signal did not vary significantly with increasing PI concentrations. In all PI
assays, 1.50 µM was therefore used.
CFDA has been shown to alter cell viability at high concentrations (> 10 µM) 41.
Therefore, in order to carry out an assay with this dye, a calibration must first be done in
order to determine the minimum concentration that would produce high fluorescence in
live cells. RAW 264.7 macrophages were seeded in a 96-well plate and left overnight to
attach to the bottom of the wells. The medium was removed and cells washed 3 times
with serum-free medium. CFDA solutions of concentrations 0.5, 1.1, 2.2, 3.5, and 4.3 µM
were then used to assess the population of live cells.
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Figure 25. Determination of the optimum CFDA concentration. RAW 264.7
macrophages were seeded in a 96-well plate and left overnight to attach to the bottom of
the wells. Cell viability was then assessed using different concentrations of CFDA. *
Statistically different from 0.5 µM (P<0.05). Values are means ± S.E.M from 4 wells.
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It is observed from Figure 25 that, above 1.1 µM, the fluorescence signal is high
enough to indicate live cells populations; therefore, 1.1 µM was used in all CFDA assays.
Selection of Optics for Fluorescence Readings
On the Fluostar Galaxy microplate reader used for fluorescence measurements, it
is possible to switch from top to bottom optics through a simple optical change. Cellbased assays are generally closer to the bottom optics, allowing more sensitive
measurements. In order to determine the optimum optics settings in our study, a PI assay
was carried out on cells incubated with 0.5 and 1.0 µM staurosporine for 20 hours.
Readings from the four possible combination of optics (bottom-bottom, bottom-top, toptop, and top-bottom) are shown in Figure 26, along with results from an MTT assay. The
percentage of dead cells relative to untreated cells was determined using the following
formulae:
MTT assay
% dead cells = {1- (At/Ac)} x 100
PI assay
% dead cells = {(Ft-Fc)/Fc} x 100
At = Absorbance of treated cells
Ac = Absorbance of control cells
Ft = Fluorescence of treated cells
Fc = Fluorescence of control cells
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Figure 26. The percentage of dead cells after 20 hours of incubation with various
concentrations of staurosporine. Untreated cells were used as negative control. The PI
assay was conducted with four different optics settings of the microplate reader *
statistically different from MTT assay results (P<0.05).
The data in Figure 26 indicate a low percentage of dead cells in untreated samples
and show a high percentage of cell death in cells treated with staurosporine. This shows
that the assay worked well. It can be seen that the PI assay carried out with bottombottom optics gives results closest to those obtained with the MTT assay. In this research,
those fluorescence readings were therefore done with bottom-bottom settings.
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Dose and time-dependent viability of RAW 264.7 macrophages treated with TPGS
(a)

Confluent (2x 106 cells/well) RAW 264.7 cells were seeded in a 96-well

plate and left overnight to attach to the bottom of the wells. They were then incubated
with TPGS-enriched medium at concentrations of 12.4, 24.8, 37.2, and 49.6 µM for 24
hours. Cell viability was determined using the PI, CFDA and MTT assays as shown in
Figures 27, 28, and 29, respectively.

Figure 27. PI assay of RAW 264.7 macrophages viability after 24 hours of incubation
with increasing concentrations of TPGS-enriched medium. Untreated cells and cells
incubated with 2 µM staurosporine (stau) were used as negative and positive controls,
respectively. * Statistically different from the negative control (P≤ 0.05). Values are
means ± S.E.M from 4 wells.
It can be observed from Figure 27 that a significant increase in the population of
dead cells occurs when macrophages are exposed overnight to concentrations of TPGS at
or greater than 12.4 µM. The high population of dead cells with the staurosporine
positive control showed that this assay worked well.
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Figure 28. RAW 264.7 macrophages viability after 24 hours of incubation with TPGS, as
measured by the CFDA assay. Untreated cells and cells incubated with 2 µM
staurosporine (stau) were used as negative and positive controls, respectively. *
Statistically different from the negative control (P≤ 0.05). Values are means ± S.E.M
from 4 wells.
It is observed from Figure 28 that the CFDA fluorescence signal produced by live
cells is significantly reduced after treatment with TPGS concentrations equal to or greater
than 12.4 µM. This indicates a decrease in the population of live cells. The low
population of live cells with the staurosporine positive control confirmed the
effectiveness of this assay.
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Figure 29. RAW 264.7 macrophages viability as measured with the MTT assay
after 24 hours incubation with TPGS. Untreated cells and cells incubated with 2 µM
staurosporine (stau) were used as negative and positive controls, respectively. *
Statistically different from the negative control (P≤ 0.05). Values are means ± S.E.M
from 4 wells.
The decrease in mitochondrial activity observed in Figure 29 with increasing
concentrations of TPGS confirms cell death is caused by TPGS concentrations ≥ 12.4 µM
and is dose-responsive. The low population of live cells with the staurosporine positive
control confirmed this assay worked well.
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(b)

To test for time-dependence, RAW 264.7 cells were seeded in a 96-well

plate and left overnight to attach to the bottom of the wells and then incubated with 24.8
µM TPGS for 0, 4, 16, and 24 hour (s). Figure 30 shows results of cell viability as
assessed with CFDA.

Figure 30. Time-dependent CFDA assay for RAW 264.7 macrophages viability after
incubation with 24.8 µM TPGS. At time 0, TPGS was added to cells then withdrawn
immediately. * Statistically different from 0 hour (P≤ 0.05). Values are means ± S.E.M
from 4 wells.
As shown in Figure 30, the population of live cells decreased with increasing time
of incubation. Significant decreases were observed at 16 hours but not at 4 hours.
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Comparative Viability of RAW 264.7 and LNCaP Cells Treated with TPGS
RAW 264.7 or LNCaP cells were seeded in 96-well plates and after an overnight
incubation in medium, then they were treated with increasing concentrations of TPGS
solutions for 24 hours. The number of live cells was assessed using the MTT assay.
Figure 31 shows the changes observed in mitochondrial activity.

Figure 31. MTT assay of RAW 264.7 and LNCaP cells incubated with TPGS for
24 hours. Untreated cells and cells incubated with 2 µM staurosporine (stau) were used
as negative and positive controls, respectively. * Statistically different from untreated
cells (P≤ 0.05). Values are means ± S.E.M from 4 wells.
It can be observed from Figure 31 that there is a decrease in mitochondrial
activity with increasing concentrations of TPGS. This indicates that cell death is dosedependent for both cell lines. However, a significant reduction in the number of live
macrophages and LNCaP cells occurred after initial treatment with 12.4 and 24.8 µM
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TPGS, respectively. The high number of cell death caused by staurosporine, the positive
control, confirmed the reliability of this assay.
Comparative Viability of RAW 264.7 and LNCaP Cells Treated with α-TS
RAW 264.7 or LNCaP cells were seeded in 96-well plates and incubated
overnight for the cells to adhere to the bottom of the well plates. They were then treated
with increasing concentrations of α-TS-enriched medium for 24 hours. The medium was
removed and the number of live cells assessed using the MTT assay. Figure 32 shows the
changes observed in mitochondrial activity.

Figure 32. MTT assay of RAW 264.7 and LNCaP cells incubated with α-TS for 24
hours. * Statistically different from the other cell line, at the same concentration (P≤
0.05). ** Statistically different from untreated cells (P≤ 0.05). Values are means ±
S.E.M from 4 wells.
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In Figure 32, the reduction in mitochondrial activity observed with increasing
concentrations of α -TS indicates that significant decrease in the number of live cells is
dose-dependent for both cell lines and occurs after treatment with concentrations of α TS ≥12.4 µM. RAW 264.7 macrophages appear to be more sensitive than LNCaP cells
when both are treated with the same concentration of α-TS. The low population of live
cells with the staurosporine positive control this assay was successful.
Cellular Uptake of TPGS and α-TS
In order to identify the cause of cell death observed after incubation of RAW
264.7 and LNCaP cells with TPGS and α-TS, the cellular uptake and hydrolysis of these
α-tocopheryl esters was measured using HPLC/ECD as described in the Methods
Section. Cells were grown then seeded in 12-well plates. They were then incubated with
TPGS or α-TS-enriched medium to allow the cellular uptake and hydrolysis. Lysis buffer
was then added to break up the cell membranes and release any cellular tocopherol,
which was then extracted in hexane and measured using HPLC/ECD. The uptake was
measured as total tocopherol whereas free α-tocopherol indicates cellular hydrolysis of
the esters. In these experiments, untreated cells were used as a control.
Dose-Dependent Uptake and Hydrolysis of TPGS and α-TS
RAW 264.7 or LNCaP cells were incubated with either TPGS or α-TS of
concentrations 24.8 or 49.6 µM TPGS for 24 hours. The amounts of free and total
tocopherol recovered from TPGS are shown in Figures 33 and 34, respectively.
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Figure 33. Cellular concentration of free tocopherol after 24 hours incubation with
TPGS. Each well contained 1 mL of TPGS–enriched medium and after incubation,
medium removal and cell washing, 1.5 mL of lysis buffer were added. α-Tocopherol
from the cell lysate was then extracted into hexane and measured using HPLC/ECD.
Lysate from untreated cells was used as control. Values are means ± S.E.M from two
experiments. * Statistical difference from the other cell line P<0.05.
As shown in Figure 33, a significant difference was observed between the levels
of free tocopherol from the hydrolysis of TPGS by RAW 264.7 macrophages and that by
LNCaP cells.
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Figure 34. Cellular concentration of total tocopherol in RAW 264.7 and LNCaP cells
after 24 hours incubation with TPGS. Each well contained 1 mL of TPGS–enriched
medium and after incubation, medium removal and cell washing, 1.5 mL of lysis buffer
were added. α-Tocopherol from the cell lysate was then extracted into hexane and
measured using HPLC/ECD. Lysate prepared from untreated cells was used as control.
Values are means ± S.E.M from two experiments. * Statistically different from the other
cell line, at the same TPGS concentration (P≤ 0.05).
The uptake of TPGS by RAW 264.7 macrophages was found to be greater than
that observed for LNCaP cells (see Figure 34). The amounts of total tocopherol decreased
with that of TPGS increasing because higher TPGS concentrations also cause more cell
death.
The intracellular uptake (pmol/well) and hydrolysis of α-TS by RAW 264.7 and
LNCaP cells, after a 24 hour incubation are shown in Figures 35 and 36, respectively.
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Figure 35. Cellular concentration of total tocopherol after 24 hours of incubation with αTS. Each well contained 1 mL of α-TS–enriched medium. After the incubation, the
medium was removed, the cells washed and 1.5 mL of lysis buffer were added. αTocopherol from the cell lysate was extracted into hexane and measured using
HPLC/ECD. Values are means ± S.E.M from two experiments. * Statistically different
from the other cell line, at the same α-TS concentration (P≤ 0.05).
As shown in Figure 35, the cellular total tocopherol was shown to increase with
increasing concentration of α-TS. RAW 264.7 macrophages took up significantly greater
amounts of α-TS than LNCaP cells.
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Figure 36. Cellular concentration of free tocopherol after 24 hours incubation with α-TS.
After 24 hours of incubation with α-TS, the medium was removed, the cells washed, and
1.5 mL of lysis buffer were added per well. Cellular α-tocopherol was then extracted into
hexane and measured using HPLC/ECD. Values are means ± S.E.M from two
experiments. * Statistically different from the other cell line, at the same α-TS
concentration (P≤ 0.05).
As shown in Figure 36, the levels of free tocopherol decreased with increasing
concentrations of α-TS. RAW 264.7 macrophages took up significantly greater amounts
of α-TS than did LNCaP cells.
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Table 3. Percentages of cellular tocopherol recovered in dose-dependent
experiments. RAW 264.7 macrophages and LNCaP cells were incubated for 24 hours
with 24.8 and 49.6 µM TPGS and α-TS. Values are means ± S.E.M from two
experiments.

TPGS, µM

Esterified

24.8

49.6

24.8

49.6

97.3

98.7

93.9

98.2

2.7

1.3

6.1

1.8

96.9

95.7

82.4

100

3.1

4.3

17.6

0.0

tocopherol,

%
RAW 264.7

α-TS, µM

TPGS and/or α-TS

macrophages
Free α−ΤΟΗ,%
Esterified

tocopherol,

%
LNCaP cells

TPGS and/or α-TS
Free α−ΤΟΗ,%

Table 3 shows that the percentages of free tocopherol from intracellular
hydrolysis of TPGS and α-TS are very small compared to the levels of TPGS and/or αTS. It can be also observed that, whereas the percentages of esterified tocopherol
significantly increase with the concentration of α-TS, the reverse is obtained for free
tocopherol. The percentages of tocopherol from TPGS did not appear to follow any
pattern. The data in Table 4, below, indicate that only a small amount of tocopherol is
taken up by cells (intracellular). Most of the TPGS or α-TS added per well remains in the
culture medium.

- 54 -

Table 4. Concentrations of intracellular and extracellular tocopherol in pmol/well.
TPGS, pmol/well

α-TS, pmol/well

24800

49600

24800

49600

5.63

5.36

3.45

10.26

24794.37

49594.64

24796.55

49589.74

Intracellular

3.3

2.04

0.39

5.59

Extracellular

24796.7

49597.96

24799.61

49594.41

Tocopherol,
Pmol/well
RAW 264.7

Intracellular

macrophages Extracellular

LNCaP cells

Time-dependent uptake and hydrolysis of TPGS
RAW 264.7 and LNCaP cells were incubated with 24.8 µM TPGS for 24, 48, and
72 hours.
Table 5. Percentages of cellular tocopherol recovered in time-dependent
experiments. RAW 264.7 macrophages and LNCaP cells were incubated with 24.8 µM
TPGS for 24, 48, and 72 hours. Values are indicated as ± S.E.M from two experiments.

TPGS
Time, hours
Esterified tocopherol, %
RAW 264.7

TPGS/ α-TS

macrophages

Free α−ΤΟΗ,%
Esterified tocopherol, %

LNCaP cells

TPGS/ α-TS
Free α−ΤΟΗ,%
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24

48

72

97.3

97.0

95.7

2.7

3.0

4.3

96.9

97.1

96.9

3.1

2.9

3.1

The data in Table 5 show that, unlike LNCaP cells, RAW 264.7 macrophages take
up and hydrolyze TPGS in a time-responsive manner. This is most likely because
macrophages contain higher levels of esterases.
Concentration Calibration Curves of α-TOH and 5, 7-DMT
In order to establish a relationship between optical density and concentration of
standard solutions, six solutions of α-TOH and 5, 7 –DMT were prepared in ethanol and
their absorbance measured using a Cary 50 Bio UV-Visible spectrophotometer. A scan
was performed with baseline correction from 200 nm to 350 nm. The maximum
absorbance at 292 nm was recorded. Beer’s law and molar extinction coefficients (ε =
3460 and 3270 cm-1M-1 for 5, 7-DMT and α-TOH, respectively) were then used to
calculate concentrations according to the formula:
C = OD/ (ελ x l)
C = Concentration in M
OD = Optical density
ε = Molar extinction coefficient, cm-1M-1
l = Pathlength of measuring light beam.
[A]= stock solution; [B] = [A]/2; [C] = [A]/4; [D] = [A]/8; [E] = [A]/16; [F] = [A]/32.
Beer’s law and molar extinction coefficients were then used to calculate concentrations.
For example, 5, 7-DMT has ελ = 3460 cm-1M-1 at 292 nm.
Solution A: [A] = 0.75/3460 = 216.18 µM
Solution B: [A]/2 = 0.37/3460 = 213.29 µM
The average of these two values was calculated as [A],
[A] = (216.18 µM + 213.29 µM)/2 = 215.04 µM
Concentrations of solutions B, C, D, E and F were then obtained from [A]:
[B]= 107.52 µM

[C] = 53.76 µM

[D] = 26.88 µM [E] = 13.44 µM [F] = 6.72 µM

Concentrations of standard α-TOH solutions were calculated the same way using
the molar extinction coefficient of 3270 cm-1M-1 at 292 nm.
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[A]= 301.69 µM [B] = 150.84 µM

[C] = 75.42 µM

[D] = 37.71 µM

[E] = 18.86 µM [F] = 9.43 µM
Linear curves of optical density versus concentration were then plotted as shown
in Figures 37 and 38 and the linear relationship obtained.
5,7−DMT: Optical density = 0.0035 (concentration) - 0.0038
α-TOH: Optical density = .0032 (concentration) + 0.0082

Figure 37. Linear relationship between optical density and concentration for 5, 7-DMT.

.
Figure 38. Linear relationship between optical density and concentration for α-TOH
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Properties of p-HATS
Oxidation Potential for Electrochemical Detection of p-HATS.
p-HATS possess a free hydroxyl group and is therefore electroactive. In order to
determine its chromatographic properties, the optimum oxidation potential for its
detection using HPLC/ECD was found. A mixture of 250 pmol p-HATS and 79 pmol of
5, 7-DMT was prepared in mobile phase and the peaks recorded at different oxidation
potentials. Figure 39 shows the p-HATS peak areas obtained as a function of the
oxidation potential used.

Figure 39. Absolute peak areas of p-HATS as a function of oxidation potential. A
solution of p-HATS and 5, 7-DMT was prepared in mobile phase and the two compounds
detected using HPLC/ECD.
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The data in Figure 39 show that no significant differences were found in the
absolute areas of p-HATS as the oxidation potential was varied. Therefore, 400 mV, the
potential used in previous experiments for the detection of α-TOH was used to analyze pHATS because this potential is optimal for vitamin E.
Retention Time of p-HATS Relative to 5, 7-DMT.
A solution of 417 pmol p-HATS, 2.30 pmol 5, 7-DMT and 2.42 pmol α-TOH was
prepared in mobile phase and injected into the HPLC for analysis. Figure 40 shows the
chromatogram obtained from this measurement.

Figure 40. Chromatogram of a mixture of p-HATS and 5, 7-DMT in mobile phase.
It can be seen from Figure 40 that p-HATS is indeed electroactive and elutes from
the column later than 5, 7-DMT and earlier than α-TOH. The absence of extra peaks
suggests that the by-product of p-HATS synthesis, p-HA, was not present as an impurity
in the sample.
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Retention Time of p-HA Relative to 5, 7-DMT.
In order to confirm that p-HA eluted at a retention time different from that of 5, 7DMT and p-HATS, a solution of 120 pmol p-HA and 55 pmol 5, 7-DMT in mobile phase
was prepared and analyzed using HPLC/ECD. The peaks obtained are shown in Figure
41.

Figure 41. Chromatogram of a solution of p-HA and 5, 7-DMT in mobile phase.
The chromatogram in Figure 41 shows that p-HA elutes from the non-polar
chromatographic column earlier than 5, 7-DMT. The position of this peak also proves the
p-HATS synthesized was free of this by-product.
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Extraction of p-HATS.
The extraction of α-TOH was carried out in hexane throughout this study. It was
therefore assumed that hexane might also be a suitable solvent for p-HATS. A solution of
25 µM p-HATS was prepared, treated with antioxidants as described earlier in the
Methods Section, and extracted into hexane. Figures 42 and 43 show the chromatograms
obtained in the mobile phase and after extraction into hexane, respectively.

Figure 42. Detector signal as a function of retention time for a solution of 750 pmol pHATS and 288 pmol 5, 7-DMT in mobile phase.
The areas under the peaks in Figure 42 were obtained and used to calculate the
response factor. F was found to be 0.6194± 0.0052.
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Figure 43. Chromatogram of a solution of p-HATS extracted into hexane.
The response factor (F=4.4906) calculated from the areas under the peaks in
Figure 43 was significantly different from that obtained in Figure 42. Much less p-HATS
was recovered for the condition in Figure 43 than in Figure 42. This suggested that
hexane is not suitable for the extraction of p-HATS. Other solvents were therefore
considered.
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The chromatograms obtained after extraction of 12.5 nmol of p-HATS into octane,
methylene chloride, and ethyl acetate are shown in Figures 44, 45, and 46, respectively.

Figure 44. Chromatogram of a solution of p-HATS extracted into octane.
Figure 44 shows that low levels of p-HATS were obtained after an extraction
using octane. The response factor (F = 5.755) obtained was very high relative to that in
Figure 42. Octane, as well as hexane, are straight hydrocarbon chains and have a polarity
index of 0.00. The amide group in p-HATS makes the compound very polar compared to
TPGS. This is the reason why methylene chloride and ethyl acetate were also evaluated.
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Figure 45. Chromatogram of a solution of p-HATS extracted into methylene chloride.
When methylene chloride was used as extracting solvent, high levels of p-HATS
were recovered. Indeed, this solvent has a polarity index of 3.1 and was shown to
solubilize p-HATS better than hexane or octane. However, it took more than an hour to
dry 500 µL of the methylene chloride under nitrogen. The response factor obtained,
0.6489, was close to the value calculated from Figure 42.
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Figure 46. Chromatogram of a solution of p-HATS extracted into ethyl acetate.
As shown in Figure 46, ethyl acetate also extracted high levels of p-HATS. From
all the solvents used, it gave a response factor (F = 0.6355) closest to the value obtained
in mobile phase. It took only 30 minutes to dry 500 µL of the ethyl acetate layer under
nitrogen. Therefore, compared to methylene chloride, it would be a better solvent for the
extraction of p-HATS.
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Hydrolysis of p-HATS.
A 25 µM solution of p-HATS was prepared in ethanol; a 500 µL aliquot was then
treated with antioxidants and saponified with 300 µL of saturated KOH for 5 minutes.
The products of p-HATS hydrolysis were then extracted into ethyl acetate and hexane
and analyzed using HPLC/ECD. Figures 47 and 48 show the peaks obtained with ethyl
acetate and hexane, respectively.

Figure 47. Chromatogram of a saponified solution of p-HATS after extraction into ethyl
acetate.
It can be seen from Figure 47 that, in addition to the internal standard peak, two
compounds elute at times 8.9 and 16.6 minutes. In Figure 41, p-HA eluted approximately
2 minutes before 5, 7-DMT. The chromatogram in Figure 40 showed that α-TOH elutes
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about 4 minutes 5, 7-DMT. These facts suggest that p-HA and α-TOH might be
hydrolysis products of p-HATS .

Figure 48. Chromatogram of a saponified solution of p-HATS after extraction into
hexane.
From figure 48, it can be observed that a low amount of p-HA eluted after 10
minutes. This confirms the fact that it is one of the hydrolysis products of p-HATS. It
should also be noted that the peak at 16.6 minutes is strong in both Figures 47 and 48,
when ethyl acetate and hexane are used, respectively. Therefore, the extracting solvent
used did not affect the recovery of the product(s). These results also suggest that the
compound is probably α-TOH.
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Figure 49. Chromatogram of a saponified solution of p-HATS after extraction into
hexane and addition of α-TOH.
To further investigate the identity of the peak at 16.6 minutes, 2.42 pmol of αTOH were added to a sample extracted in hexane after saponification and the mixture
was analyzed using HPLC/ECD. The chromatogram obtained is shown in Figure 49. The
detector signal due to α-TOH is significantly greater than the one in Figure 48. This
showed that, indeed, α-TOH is a hydrolysis product of p-HATS.
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CHAPTER 4
DISCUSSION
The purpose of this research was to investigate and compare the toxicity and
uptake of TPGS and α-TS by RAW 264.7 and LNCaP cells. Both esters are hydrolyzed
intracellularly to produce α-TOH. α-TS is also a hydrolysis product of TPGS. Cell
viability measured by PI, CFDA and MTT assays indicated that RAW 264.7
macrophages are killed when exposed overnight to concentrations of TPGS at or greater
than 12.4 µM. LNCaP cells treated in similar experimental conditions show significant
cell death with TPGS concentrations at or greater than 24.8 µM. However, it is noted
from Figure 30 that both cell lines start dying when treated overnight with initial
concentrations of 12.4 µM α-TS. Hence, 12.4 µM of α-TS would kill RAW 264.7 or
LNCaP cells macrophages after 24 hours but 12.4 µM of TPGS would kill only RAW
264.7 macrophages after such time. These results suggest that α-TS might be more
cytotoxic than TPGS.
From the results in Figure 30, it can be concluded that RAW 264.7 are more
sensitive than LNCaP cells when both are treated for 24 hours with the same
concentration of α-TS. This can be explained by the fact that macrophages contain high
levels of esterases. This raises the question of the real cause of cell death observed. To
determine whether cytotoxicity is due to TPGS and/or one of its hydrolysis products, the
uptake and hydrolysis of TPGS and α-TS must be taken into consideration.
α-TOH, PEG 1000, and succinate do not cause cell death42. The cytotoxic
substances in this study are, therefore, TPGS itself, α-TS or both. Table 4 shows that the
tocopherol taken up by cells mostly remains as TPGS and/or α-TS. Percentages of
cellular α-TOH are very low further reinforcing the notion that free tocopherol is not
responsible for the observed toxicity. It is shown in Figures 31-34 that macrophages take
up more TPGS or α-TS than LNCaP cells do. This explains their cell death at lower
initial concentrations of TPGS. It can be said from all these facts that RAW 264.7 and
LNCaP cells treated with TPGS die due to TPGS and /or α-TS, but not α-TOH.
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In an attempt to distinguish which one of the two esters killed cells, an anilide
derivative of α-TS, p-HATS was considered as an analytical tool. Unlike α-TS, p-HATS
has a free hydroxyl group and can therefore be detected using HPLC/ECD. A sample
containing TPGS and α-TS could be used as a starting reagent in order to synthesize pHATS. Based on the assumption that only α-TS would react, measurement of p-HATS
by HPLC would then give an indication of how much α-TS was in the starting material.
This aspect was not further developed in this research; however, some critical properties
of p-HATS were studied.
The data in Figure 38 indicate that 400 mV, the optimal potential for detection of
vitamin E compounds, can also be used to detect p-HATS. The chromatograms in Figures
39 and 40 show that p-HA, 5, 7-DMT , p-HATS, and α-TOH elute from the column in
the order p-HA< 5, 7-DMT < p-HATS< α-TOH.
The extraction of p-HATS in hexane, octane, methylene chloride, and ethyl
acetate were also carried out. Hexane and octane give a very low recover of p-HATS
compared to the mobile phase. This can be explained by the fact that the amide side chain
in p-HATS is highly polar compared to the PEG 1000 moiety in TPGS. Hexane and
octane are straight hydrocarbon chains and both have a polarity index of 0.0043.
Therefore, even though they are suitable for the extraction of TPGS and α-TS, they do
not solubilize p-HATS at high levels. Methylene chloride and ethyl acetate are two
compounds with polarity indexes 3.1 and 4.4, respectively. They were both found to
extract high levels of p-HATS, as can be seen from the response factors 0.6489 and
0.6355, respectively, compared to 0.6194 in the mobile phase. Ethyl acetate was shown to
dry faster under nitrogen than methylene chloride and the background noise in Figure 44
was less than the one in Figure 43. Therefore, to extract p-HATS, ethyl acetate was the
best solvent among the four that were evaluated.
In order to identify the hydrolysis product(s) of p-HATS, saponification of the
ester with saturated KOH was carried out. Possible compounds include p-HA, α-TOH,
succinate, and α-TS. The results from Figures 45 and 46 indicate that p-HA is produced
in low amounts by the hydrolysis of p-HATS. The strong peak that elutes after 16.6
minutes after extraction in methylene chloride or hexane is an indication that the
compound is not highly polar. Indeed, if the amide group was still part of the compound,
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its recovery in hexane would be low. α-TS and succinate are not electroactive species.
These facts suggest that α-TOH might be the compound that elutes after 16.6 minutes.
This hypothesis is further confirmed by the fact that the detector signal is increased, in
Figure 49, when extra α-TOH is added to the saponified sample. Therefore, α-TOH is a
hydrolysis product of p-HATS. If carried out successfully, the use of a cell extract
containing TPGS and α-TS as a starting material in the synthesis of p-HATS would
reveal what levels of α-TS are left in the cells and confirm whether cytotoxicity is caused
by TPGS alone or by a combination of both esters. The toxicity and uptake of TPGS by
normal cells remain to be addressed.
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CHAPTER 5
CONCLUSION
This research, which included the cellular toxicity and uptake of TPGS and α-TS
as well as critical properties of p-HATS, gave the following results:
a)

Overnight treatment of RAW 264.7 macrophages with TPGS concentrations

at or greater than 12.4 µM cause cell death. LNCaP cells are killed under the same
conditions with TPGS concentrations of at least 24.8 µM. Both cell lines start dying
when treated overnight with at least 12.4 µM. These data suggest that α-TS is more
cytotoxic than TPGS.
b)

RAW 264.7 are more sensitive than LNCaP cells when treated overnight with

similar concentrations of α-TS.
c)

When both cell lines are incubated with 24.8 µM TPGS or α-TS for 24 hours,

higher concentrations of total tocopherol are obtained from TPGS than from α-TS.
d)

RAW 264.7 macrophages take up more TPGS or α-TS than LNCaP cells do.

e)

Cellular total tocopherol consists mainly of TPGS and/or α-TS. Very low

levels of α-TOH are in the cell. These facts suggest that the observed cell death is due to
TPGS and/or α-TS but not α-TOH.
f)

p-HATS is an electroactive species and can be detected effectively using

HPLC/ECD.
g)

P-HATS can be detected using 400 mV, the oxidation potential for the

detection of vitamin E compounds.
h)

The use of ethyl acetate as an extraction solvent gives a good recovery of p-

HATS from samples.
i)

p-HA and α-TOH are hydrolysis product of p-HATS.
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APPENDIX
Stereoisomers of RRR-α-Tocopherol
Chemical structures of the 8 stereoisomeric forms of tocopherol are shown below:
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Staurosporine
This is a microbial alkaloid isolated from Streptomyces species. It has a strong
toxic effect on the growth of various mammalian cells and, as such, was used in cell
viability experiments as positive control. The chemical structure of staurosporine is
shown below:
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Structure of staurosporine
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